Abstract Details

Title Tanezumab Does Not Cause Sympathetic Nervous System Dysfunction in Clinical Osteoarthritis Studies

Topic Pain

Presentation(s) (-)

Poster/Presentation
Number 303

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark T. Brown, MD (Pfizer Inc.) PRESENTER	Dr. Brown has received personal compensation for serving as an employee of Pfizer Inc. Dr. Brown has received stock or an ownership interest from Pfizer Inc.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Patrick F. Chinnery, MRCP (University of Cambridge)	No disclosure on file

��ɫ����